Skip to main content
Top
Published in: Acta Diabetologica 4/2012

Open Access 01-08-2012 | Original Article

Molecular mechanisms of muscarinic acetylcholine receptor–stimulated increase in cytosolic free Ca2+ concentration and ERK1/2 activation in the MIN6 pancreatic β-cell line

Authors: Joanne L. Selway, Claire E. Moore, Rajendra Mistry, R. A. John Challiss, Terence P. Herbert

Published in: Acta Diabetologica | Issue 4/2012

Login to get access

Abstract

Muscarinic acetylcholine receptor (mAChR) activation of pancreatic β-cells elevates intracellular Ca2+ and potentiates glucose-stimulated insulin secretion. In addition, it activates a number of signaling molecules, including ERK1/2, whose activation has been shown to play an important role in regulating pancreatic β-cell function and mass. The aim of this work was to determine how mAChR activation elevates intracellular Ca2+ concentration ([Ca2+] i ) and activates ERK1/2 in the pancreatic β-cell line MIN6. We demonstrate that agonist-stimulated ERK1/2 activation is dependent on the activation of phospholipase C and an elevation in [Ca2+] i , but is independent of the activation of diacylglycerol-dependent protein kinase C isoenzymes. Using a pharmacological approach, we provide evidence that agonist-induced increases in [Ca2+] i and ERK activity require (1) IP3 receptor-mediated mobilization of Ca2+ from the endoplasmic reticulum, (2) influx of extracellular Ca2+ through store-operated channels, (3) closure of KATP channels, and (4) Ca2+ entry via L-type voltage-operated Ca2+ channels. Moreover, this Ca2+-dependent activation of ERK is mediated via both Ras-dependent and Ras-independent mechanisms. In summary, this study provides important insights into the multifactorial signaling mechanisms linking mAChR activation to increases in [Ca2+] i and ERK activity.
Literature
1.
go back to reference Ahren B (2000) Autonomic regulation of islet hormone secretion—implications for health and disease. Diabetologia 43(4):393–410PubMedCrossRef Ahren B (2000) Autonomic regulation of islet hormone secretion—implications for health and disease. Diabetologia 43(4):393–410PubMedCrossRef
2.
go back to reference Gilon P, Henquin JC (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 22(5):565–604PubMedCrossRef Gilon P, Henquin JC (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 22(5):565–604PubMedCrossRef
3.
go back to reference Gautam D, Han SJ, Hamdan FF, Jeon J, Li B, Li JH, Cui Y, Mears D, Lu H, Deng C, Heard T, Wess J (2006) A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3(6):449–461. doi:10.1016/j.cmet.2006.04.009 PubMedCrossRef Gautam D, Han SJ, Hamdan FF, Jeon J, Li B, Li JH, Cui Y, Mears D, Lu H, Deng C, Heard T, Wess J (2006) A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab 3(6):449–461. doi:10.​1016/​j.​cmet.​2006.​04.​009 PubMedCrossRef
4.
go back to reference Kanat M, Norton L, Winnier D, Jenkinson C, Defronzo RA, Abdul-Ghani MA Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. Acta Diabetol. doi:10.1007/s00592-011-0285-x Kanat M, Norton L, Winnier D, Jenkinson C, Defronzo RA, Abdul-Ghani MA Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. Acta Diabetol. doi:10.​1007/​s00592-011-0285-x
6.
go back to reference Iismaa TP, Kerr EA, Wilson JR, Carpenter L, Sims N, Biden TJ (2000) Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes 49(3):392–398PubMedCrossRef Iismaa TP, Kerr EA, Wilson JR, Carpenter L, Sims N, Biden TJ (2000) Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes 49(3):392–398PubMedCrossRef
7.
go back to reference Tang SH, Sharp GW (1997) Identification of muscarinic receptor subtypes in RINm5F cells by means of polymerase chain reaction, subcloning, and DNA sequencing. Diabetes 46(9):1419–1423PubMedCrossRef Tang SH, Sharp GW (1997) Identification of muscarinic receptor subtypes in RINm5F cells by means of polymerase chain reaction, subcloning, and DNA sequencing. Diabetes 46(9):1419–1423PubMedCrossRef
8.
go back to reference Boschero AC, Szpak-Glasman M, Carneiro EM, Bordin S, Paul I, Rojas E, Atwater I (1995) Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors. Am J Physiol 268 (2 Pt 1):E336–E342 Boschero AC, Szpak-Glasman M, Carneiro EM, Bordin S, Paul I, Rojas E, Atwater I (1995) Oxotremorine-m potentiation of glucose-induced insulin release from rat islets involves M3 muscarinic receptors. Am J Physiol 268 (2 Pt 1):E336–E342
9.
go back to reference Gautam D, Han SJ, Duttaroy A, Mears D, Hamdan FF, Li JH, Cui Y, Jeon J, Wess J (2007) Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis. Diabetes Obes Metab 9(Suppl 2):158–169 Gautam D, Han SJ, Duttaroy A, Mears D, Hamdan FF, Li JH, Cui Y, Jeon J, Wess J (2007) Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis. Diabetes Obes Metab 9(Suppl 2):158–169
10.
go back to reference Bonner TI (1989) New subtypes of muscarinic acetylcholine receptors. Trends Pharmacol Sci 10(Suppl):11–15 Bonner TI (1989) New subtypes of muscarinic acetylcholine receptors. Trends Pharmacol Sci 10(Suppl):11–15
11.
go back to reference Kim JY, Yang MS, Oh CD, Kim KT, Ha MJ, Kang SS, Chun JS (1999) Signalling pathway leading to an activation of mitogen-activated protein kinase by stimulating M3 muscarinic receptor. Biochem J 337(Pt 2):275–280PubMedCrossRef Kim JY, Yang MS, Oh CD, Kim KT, Ha MJ, Kang SS, Chun JS (1999) Signalling pathway leading to an activation of mitogen-activated protein kinase by stimulating M3 muscarinic receptor. Biochem J 337(Pt 2):275–280PubMedCrossRef
12.
go back to reference Wylie PG, Challiss RA, Blank JL (1999) Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors. Biochem J 338(Pt 3):619–628PubMedCrossRef Wylie PG, Challiss RA, Blank JL (1999) Regulation of extracellular-signal regulated kinase and c-Jun N-terminal kinase by G-protein-linked muscarinic acetylcholine receptors. Biochem J 338(Pt 3):619–628PubMedCrossRef
13.
go back to reference Yagle K, Lu H, Guizzetti M, Moller T, Costa LG (2001) Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: role in DNA synthesis and effect of ethanol. Glia 35(2):111–120PubMedCrossRef Yagle K, Lu H, Guizzetti M, Moller T, Costa LG (2001) Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: role in DNA synthesis and effect of ethanol. Glia 35(2):111–120PubMedCrossRef
14.
go back to reference Barbosa HC, Bordin S, Anhe G, Persaud SJ, Bowe J, Borelli MI, Gagliardino JJ, Boschero AC (2008) Islet neogenesis-associated protein signaling in neonatal pancreatic rat islets: involvement of the cholinergic pathway. J Endocrinol 199(2):299–306PubMedCrossRef Barbosa HC, Bordin S, Anhe G, Persaud SJ, Bowe J, Borelli MI, Gagliardino JJ, Boschero AC (2008) Islet neogenesis-associated protein signaling in neonatal pancreatic rat islets: involvement of the cholinergic pathway. J Endocrinol 199(2):299–306PubMedCrossRef
16.
go back to reference Costes S, Broca C, Bertrand G, Lajoix AD, Bataille D, Bockaert J, Dalle S (2006) ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival. Diabetes 55(8):2220–2230PubMedCrossRef Costes S, Broca C, Bertrand G, Lajoix AD, Bataille D, Bockaert J, Dalle S (2006) ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival. Diabetes 55(8):2220–2230PubMedCrossRef
17.
go back to reference Friedrichsen BN, Neubauer N, Lee YC, Gram VK, Blume N, Petersen JS, Nielsen JH, Moldrup A (2006) Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol 188(3):481–492PubMedCrossRef Friedrichsen BN, Neubauer N, Lee YC, Gram VK, Blume N, Petersen JS, Nielsen JH, Moldrup A (2006) Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways. J Endocrinol 188(3):481–492PubMedCrossRef
18.
go back to reference Longuet C, Broca C, Costes S, Hani EH, Bataille D, Dalle S (2005) Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of Langerhans. Endocrinology 146(2):643–654PubMedCrossRef Longuet C, Broca C, Costes S, Hani EH, Bataille D, Dalle S (2005) Extracellularly regulated kinases 1/2 (p44/42 mitogen-activated protein kinases) phosphorylate synapsin I and regulate insulin secretion in the MIN6 beta-cell line and islets of Langerhans. Endocrinology 146(2):643–654PubMedCrossRef
19.
go back to reference Gomez E, Powell ML, Bevington A, Herbert TP (2008) A decrease in cellular energy status stimulates PERK-dependent eIF2alpha phosphorylation and regulates protein synthesis in pancreatic beta-cells. Biochem J 410(3):485–493PubMedCrossRef Gomez E, Powell ML, Bevington A, Herbert TP (2008) A decrease in cellular energy status stimulates PERK-dependent eIF2alpha phosphorylation and regulates protein synthesis in pancreatic beta-cells. Biochem J 410(3):485–493PubMedCrossRef
20.
go back to reference Palmer AE, Jin C, Reed JC, Tsien RY (2004) Bcl-2-mediated alterations in endoplasmic reticulum Ca2+ analyzed with an improved genetically encoded fluorescent sensor. Proc Natl Acad Sci USA 101(50):17404–17409PubMedCrossRef Palmer AE, Jin C, Reed JC, Tsien RY (2004) Bcl-2-mediated alterations in endoplasmic reticulum Ca2+ analyzed with an improved genetically encoded fluorescent sensor. Proc Natl Acad Sci USA 101(50):17404–17409PubMedCrossRef
21.
go back to reference Babwah AV, Dale LB, Ferguson SS (2003) Protein kinase C isoform-specific differences in the spatial-temporal regulation and decoding of metabotropic glutamate receptor1a-stimulated second messenger responses. J Biol Chem 278(7):5419–5426PubMedCrossRef Babwah AV, Dale LB, Ferguson SS (2003) Protein kinase C isoform-specific differences in the spatial-temporal regulation and decoding of metabotropic glutamate receptor1a-stimulated second messenger responses. J Biol Chem 278(7):5419–5426PubMedCrossRef
22.
go back to reference Gnudi L, Frevert EU, Houseknecht KL, Erhardt P, Kahn BB (1997) Adenovirus-mediated gene transfer of dominant negative ras(asn17) in 3T3L1 adipocytes does not alter insulin-stimulated P13-kinase activity or glucose transport. Mol Endocrinol 11(1):67–76PubMedCrossRef Gnudi L, Frevert EU, Houseknecht KL, Erhardt P, Kahn BB (1997) Adenovirus-mediated gene transfer of dominant negative ras(asn17) in 3T3L1 adipocytes does not alter insulin-stimulated P13-kinase activity or glucose transport. Mol Endocrinol 11(1):67–76PubMedCrossRef
23.
go back to reference Gomez E, Pritchard C, Herbert TP (2002) cAMP-dependent protein kinase and Ca2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic beta-cells. J Biol Chem 277(50):48146–48151PubMedCrossRef Gomez E, Pritchard C, Herbert TP (2002) cAMP-dependent protein kinase and Ca2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic beta-cells. J Biol Chem 277(50):48146–48151PubMedCrossRef
24.
go back to reference Moore CE, Xie J, Gomez E, Herbert TP (2009) Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic beta-cells. J Mol Biol 389(3):480–494PubMedCrossRef Moore CE, Xie J, Gomez E, Herbert TP (2009) Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic beta-cells. J Mol Biol 389(3):480–494PubMedCrossRef
25.
go back to reference Willars GB, Nahorski SR, Challiss RA (1998) Differential regulation of muscarinic acetylcholine receptor-sensitive polyphosphoinositide pools and consequences for signaling in human neuroblastoma cells. J Biol Chem 273(9):5037–5046PubMedCrossRef Willars GB, Nahorski SR, Challiss RA (1998) Differential regulation of muscarinic acetylcholine receptor-sensitive polyphosphoinositide pools and consequences for signaling in human neuroblastoma cells. J Biol Chem 273(9):5037–5046PubMedCrossRef
26.
go back to reference Berridge MJ, Irvine RF (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312(5992):315–321PubMedCrossRef Berridge MJ, Irvine RF (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312(5992):315–321PubMedCrossRef
27.
go back to reference Lu Z, Liu D, Hornia A, Devonish W, Pagano M, Foster DA (1998) Activation of protein kinase C triggers its ubiquitination and degradation. Mol Cell Biol 18(2):839–845PubMed Lu Z, Liu D, Hornia A, Devonish W, Pagano M, Foster DA (1998) Activation of protein kinase C triggers its ubiquitination and degradation. Mol Cell Biol 18(2):839–845PubMed
28.
go back to reference Wilkinson SE, Parker PJ, Nixon JS (1993) Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294(Pt 2):335–337PubMed Wilkinson SE, Parker PJ, Nixon JS (1993) Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294(Pt 2):335–337PubMed
29.
go back to reference Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268(13):9194–9197 Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268(13):9194–9197
30.
go back to reference Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F et al (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266(24):15771–15781PubMed Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F et al (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266(24):15771–15781PubMed
31.
go back to reference Missiaen L, Callewaert G, De Smedt H, Parys JB (2001) 2-Aminoethoxydiphenyl borate affects the inositol 1, 4, 5-trisphosphate receptor, the intracellular Ca2+ pump and the non-specific Ca2+ leak from the non-mitochondrial Ca2+ stores in permeabilized A7r5 cells. Cell Calcium 29(2):111–116. doi:10.1054/ceca.2000.0163 PubMedCrossRef Missiaen L, Callewaert G, De Smedt H, Parys JB (2001) 2-Aminoethoxydiphenyl borate affects the inositol 1, 4, 5-trisphosphate receptor, the intracellular Ca2+ pump and the non-specific Ca2+ leak from the non-mitochondrial Ca2+ stores in permeabilized A7r5 cells. Cell Calcium 29(2):111–116. doi:10.​1054/​ceca.​2000.​0163 PubMedCrossRef
32.
go back to reference Henquin JC, Garcia MC, Bozem M, Hermans MP, Nenquin M (1988) Muscarinic control of pancreatic B cell function involves sodium-dependent depolarization and calcium influx. Endocrinology 122(5):2134–2142PubMedCrossRef Henquin JC, Garcia MC, Bozem M, Hermans MP, Nenquin M (1988) Muscarinic control of pancreatic B cell function involves sodium-dependent depolarization and calcium influx. Endocrinology 122(5):2134–2142PubMedCrossRef
33.
go back to reference Shyng SL, Nichols CG (1998) Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science 282(5391):1138–1141PubMedCrossRef Shyng SL, Nichols CG (1998) Membrane phospholipid control of nucleotide sensitivity of KATP channels. Science 282(5391):1138–1141PubMedCrossRef
34.
go back to reference Nakano K, Suga S, Takeo T, Ogawa Y, Suda T, Kanno T, Wakui M (2002) Intracellular Ca2+ modulation of ATP-sensitive K(+) channel activity in acetylcholine-induced activation of rat pancreatic beta-cells. Endocrinology 143(2):569–576PubMedCrossRef Nakano K, Suga S, Takeo T, Ogawa Y, Suda T, Kanno T, Wakui M (2002) Intracellular Ca2+ modulation of ATP-sensitive K(+) channel activity in acetylcholine-induced activation of rat pancreatic beta-cells. Endocrinology 143(2):569–576PubMedCrossRef
35.
go back to reference Lin CW, Yan F, Shimamura S, Barg S, Shyng SL (2005) Membrane phosphoinositides control insulin secretion through their effects on ATP-sensitive K + channel activity. Diabetes 54(10):2852–2858PubMedCrossRef Lin CW, Yan F, Shimamura S, Barg S, Shyng SL (2005) Membrane phosphoinositides control insulin secretion through their effects on ATP-sensitive K + channel activity. Diabetes 54(10):2852–2858PubMedCrossRef
36.
go back to reference Kavran JM, Klein DE, Lee A, Falasca M, Isakoff SJ, Skolnik EY, Lemmon MA (1998) Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains. J Biol Chem 273(46):30497–30508PubMedCrossRef Kavran JM, Klein DE, Lee A, Falasca M, Isakoff SJ, Skolnik EY, Lemmon MA (1998) Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains. J Biol Chem 273(46):30497–30508PubMedCrossRef
37.
go back to reference Hirose K, Kadowaki S, Tanabe M, Takeshima H, Iino M (1999) Spatiotemporal dynamics of inositol 1, 4, 5-trisphosphate that underlies complex Ca2+ mobilization patterns. Science 284(5419):1527–1530PubMedCrossRef Hirose K, Kadowaki S, Tanabe M, Takeshima H, Iino M (1999) Spatiotemporal dynamics of inositol 1, 4, 5-trisphosphate that underlies complex Ca2+ mobilization patterns. Science 284(5419):1527–1530PubMedCrossRef
38.
go back to reference Nash MS, Young KW, Challiss RA, Nahorski SR (2001) Intracellular signalling. Receptor-specific messenger oscillations. Nature 413(6854):381–382. doi:10.1038/35096643 Nash MS, Young KW, Challiss RA, Nahorski SR (2001) Intracellular signalling. Receptor-specific messenger oscillations. Nature 413(6854):381–382. doi:10.​1038/​35096643
39.
go back to reference Okubo Y, Kakizawa S, Hirose K, Iino M (2001) Visualization of IP(3) dynamics reveals a novel AMPA receptor-triggered IP(3) production pathway mediated by voltage-dependent Ca2+ influx in Purkinje cells. Neuron 32(1):113–122PubMedCrossRef Okubo Y, Kakizawa S, Hirose K, Iino M (2001) Visualization of IP(3) dynamics reveals a novel AMPA receptor-triggered IP(3) production pathway mediated by voltage-dependent Ca2+ influx in Purkinje cells. Neuron 32(1):113–122PubMedCrossRef
40.
41.
go back to reference Tamarina NA, Kuznetsov A, Rhodes CJ, Bindokas VP, Philipson LH (2005) Inositol (1, 4, 5)-trisphosphate dynamics and intracellular calcium oscillations in pancreatic beta-cells. Diabetes 54(11):3073–3081PubMedCrossRef Tamarina NA, Kuznetsov A, Rhodes CJ, Bindokas VP, Philipson LH (2005) Inositol (1, 4, 5)-trisphosphate dynamics and intracellular calcium oscillations in pancreatic beta-cells. Diabetes 54(11):3073–3081PubMedCrossRef
42.
go back to reference Xia F, Gao X, Kwan E, Lam PP, Chan L, Sy K, Sheu L, Wheeler MB, Gaisano HY, Tsushima RG (2004) Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 279(23):24685–24691. doi:10.1074/jbc.M314314200 Xia F, Gao X, Kwan E, Lam PP, Chan L, Sy K, Sheu L, Wheeler MB, Gaisano HY, Tsushima RG (2004) Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 279(23):24685–24691. doi:10.​1074/​jbc.​M314314200
43.
go back to reference Venkatachalam K, van Rossum DB, Patterson RL, Ma HT, Gill DL (2002) The cellular and molecular basis of store-operated calcium entry. Nat Cell Biol 4(11):E263–E272PubMedCrossRef Venkatachalam K, van Rossum DB, Patterson RL, Ma HT, Gill DL (2002) The cellular and molecular basis of store-operated calcium entry. Nat Cell Biol 4(11):E263–E272PubMedCrossRef
44.
go back to reference Parekh AB, Penner R (1997) Store depletion and calcium influx. Physiol Rev 77(4):901–930PubMed Parekh AB, Penner R (1997) Store depletion and calcium influx. Physiol Rev 77(4):901–930PubMed
45.
go back to reference Putney JW Jr, Broad LM, Braun FJ, Lievremont JP, Bird GS (2001) Mechanisms of capacitative calcium entry. J Cell Sci 114(Pt 12):2223–2229PubMed Putney JW Jr, Broad LM, Braun FJ, Lievremont JP, Bird GS (2001) Mechanisms of capacitative calcium entry. J Cell Sci 114(Pt 12):2223–2229PubMed
46.
go back to reference Mears D, Zimliki CL (2004) Muscarinic agonists activate Ca2+ store-operated and -independent ionic currents in insulin-secreting HIT-T15 cells and mouse pancreatic beta-cells. J Membr Biol 197(1):59–70. doi:10.1007/s00232-003-0642-y PubMedCrossRef Mears D, Zimliki CL (2004) Muscarinic agonists activate Ca2+ store-operated and -independent ionic currents in insulin-secreting HIT-T15 cells and mouse pancreatic beta-cells. J Membr Biol 197(1):59–70. doi:10.​1007/​s00232-003-0642-y PubMedCrossRef
47.
go back to reference Liu YJ, Gylfe E (1997) Store-operated Ca2+ entry in insulin-releasing pancreatic beta-cells. Cell Calcium 22(4):277–286PubMedCrossRef Liu YJ, Gylfe E (1997) Store-operated Ca2+ entry in insulin-releasing pancreatic beta-cells. Cell Calcium 22(4):277–286PubMedCrossRef
48.
go back to reference Worley JF III, McIntyre MS, Spencer B, Mertz RJ, Roe MW, Dukes ID (1994) Endoplasmic reticulum calcium store regulates membrane potential in mouse islet beta-cells. J Biol Chem 269(20):14359–14362PubMed Worley JF III, McIntyre MS, Spencer B, Mertz RJ, Roe MW, Dukes ID (1994) Endoplasmic reticulum calcium store regulates membrane potential in mouse islet beta-cells. J Biol Chem 269(20):14359–14362PubMed
49.
go back to reference Bertram R, Smolen P, Sherman A, Mears D, Atwater I, Martin F, Soria B (1995) A role for calcium release-activated current (CRAC) in cholinergic modulation of electrical activity in pancreatic beta-cells. Biophys J 68(6):2323–2332PubMedCrossRef Bertram R, Smolen P, Sherman A, Mears D, Atwater I, Martin F, Soria B (1995) A role for calcium release-activated current (CRAC) in cholinergic modulation of electrical activity in pancreatic beta-cells. Biophys J 68(6):2323–2332PubMedCrossRef
50.
go back to reference Gilon P, Arredouani A, Gailly P, Gromada J, Henquin JC (1999) Uptake and release of Ca2+ by the endoplasmic reticulum contribute to the oscillations of the cytosolic Ca2+ concentration triggered by Ca2+ influx in the electrically excitable pancreatic B-cell. J Biol Chem 274(29):20197–20205PubMedCrossRef Gilon P, Arredouani A, Gailly P, Gromada J, Henquin JC (1999) Uptake and release of Ca2+ by the endoplasmic reticulum contribute to the oscillations of the cytosolic Ca2+ concentration triggered by Ca2+ influx in the electrically excitable pancreatic B-cell. J Biol Chem 274(29):20197–20205PubMedCrossRef
51.
go back to reference Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC (1998) RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. Science 280(5366):1082–1086PubMedCrossRef Ebinu JO, Bottorff DA, Chan EY, Stang SL, Dunn RJ, Stone JC (1998) RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. Science 280(5366):1082–1086PubMedCrossRef
52.
go back to reference Farnsworth CL, Freshney NW, Rosen LB, Ghosh A, Greenberg ME, Feig LA (1995) Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature 376(6540):524–527PubMedCrossRef Farnsworth CL, Freshney NW, Rosen LB, Ghosh A, Greenberg ME, Feig LA (1995) Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF. Nature 376(6540):524–527PubMedCrossRef
53.
go back to reference Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ (2003) Differential activation mechanisms of Erk-1/2 and p70(S6 K) by glucose in pancreatic beta-cells. Diabetes 52(4):974–983PubMedCrossRef Briaud I, Lingohr MK, Dickson LM, Wrede CE, Rhodes CJ (2003) Differential activation mechanisms of Erk-1/2 and p70(S6 K) by glucose in pancreatic beta-cells. Diabetes 52(4):974–983PubMedCrossRef
54.
go back to reference Renuka TR, Savitha B, Paulose CS (2005) Muscarinic M1 and M3 receptor binding alterations in pancreas during pancreatic regeneration of young rats. Endocr Res 31(4):259–270PubMedCrossRef Renuka TR, Savitha B, Paulose CS (2005) Muscarinic M1 and M3 receptor binding alterations in pancreas during pancreatic regeneration of young rats. Endocr Res 31(4):259–270PubMedCrossRef
Metadata
Title
Molecular mechanisms of muscarinic acetylcholine receptor–stimulated increase in cytosolic free Ca2+ concentration and ERK1/2 activation in the MIN6 pancreatic β-cell line
Authors
Joanne L. Selway
Claire E. Moore
Rajendra Mistry
R. A. John Challiss
Terence P. Herbert
Publication date
01-08-2012
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2012
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-011-0314-9

Other articles of this Issue 4/2012

Acta Diabetologica 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.